Status In progress
Process STA pre-2018
ID number 938

Provisional Schedule

Expected publication 31 October 2018

Project Team

Project lead Donna Barnes

Email enquiries

Consultees

Companies sponsors Roche
Others Department of Health and Social Care
  NHS England
  Welsh Government
Patient carer groups Multiple Sclerosis Society
  Multiple Sclerosis Trust
Professional groups Association of British Neurologists
  Royal College of Physicians
  UK Clinical Pharmacy Association

Commentators

Comparator companies None
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Welsh Health Specialised Services Committee
Relevant research groups None

Timeline

Key events during the development of the guidance:

Date Update
06 June 2018 Committee meeting
16 November 2017 Following an update from the company on the regulatory process, this appraisal will be rescheduled to ensure the company can provide a submission relevant to the final indication wording. As a result, the discussion of this appraisal planned for Tuesday 06 March 2018 has been cancelled. The closing date for submissions will also be extended. Details of the updated timelines for this appraisal will be sent to stakeholders and published on the NICE website in due course.
02 October 2017 Invitation to participate
23 June 2017 Following on from advice received from the company this appraisal has been rescheduled. Therefore, we now anticipate that the appraisal will begin during late September 2017 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately late November 2017.
25 January 2017 Draft scope documents
05 December 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance